Expression of CCN5 was upregulated after ACEI treatment, which further reversed myocardial fibrosis and protected heart function via inhibition of TGF-β1 signaling and fibroblast-to-myofibroblast transition. The gene discussed is TGFB1; the disease is Myocardial fibrosis.